Amgen Inc. is a large biotechnology company that develops and sells prescription medicines. Its filings show it lobbied Congress on health and pharmaceutical industry issues, likely matters affecting drug regulation, access, or pricing. The company reported $140,000 across four filings and used the firm HillNorth LLC for lobbying work.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
DOUG SCHWARTZ
The latest disclosures for this client.
HILLNORTH LLC
Q1HILLNORTH LLC
Q4The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
HILLNORTH LLC
HILLNORTH LLC
Q3HILLNORTH LLC
Q2HILLNORTH LLC
Q1